Instances include HER2+ markers and interferon gamma response in GSE75688 breast cancer data (cluster 2), and SOM D markers and epithelial-mesenchymal transition in GSE81383 melanoma data (cluster 3). This evidence concerns the gene ERBB2 and melanoma.